SCHEMBL218043

SCHEMBL218043

c1cc2sccc2nn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29671085 0.98 ALDH1A1 (0.32)
Bromide SCHEMBL29671076 0.98 ALDH1A1 (0.32)
SCHEMBL31514293 0.98 ALDH1A1 (0.32)
Phenanthrene SCHEMBL28611261 0.84 CYP3A4 (0.41)
SCHEMBL9196285 0.73 KDM4E (0.37)
SCHEMBL2426599 0.70 PDPK1 (0.39)
Cinnoline SCHEMBL28244175 0.69 RAB9A (0.39)
SCHEMBL29368123 0.67
SCHEMBL23806 0.67
SCHEMBL219949 0.67 PKM (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 533 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250072277-A1 LIGHT EMITTING ELEMENT AND DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2025-02-27 US claimed
CN-119521943-A Light emitting element and display device including the same 三星显示有限公司 2025-02-25 CN claimed
WO-2024227701-A1 PYRIDAZINE COMPOUNDS FOR TREATMENT OF FIBROTIC DISEASES Tietze Chemical Consulting UG (haftungsbeschränkt) (DE) 2024-11-07 WO claimed
EP-4458358-A1 PYRIDAZINE COMPOUNDS FOR ANTIFIBROTIC THERAPY Tietze Chemical Consulting UG (DE) 2024-11-06 EP claimed
US-20230263049-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-08-17 US claimed
CN-115605484-A Crystal form of thienopyridazine compound and preparation method and application thereof 浙江医药股份有限公司新昌制药厂(CN) 2023-01-13 CN claimed
US-20220029111-A1 Composition for Light-Emitting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2022-01-27 US claimed
US-20210288269-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2021-09-16 US claimed
CN-113354687-A Organic electroluminescent material and device 环球展览公司 2021-09-07 CN claimed
CN-113056539-A Composition for light-emitting device 株式会社半导体能源研究所 2021-06-29 CN claimed
EP-1709052-B1 DERIVATIVES OF 1,4-DIAZABICYCLO 3.2.1OCTANECARBOXAMIDE, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS SANOFI AVENTIS (FR) 2011-04-27 EP claimed
US-20100317675-A1 6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2010-12-16 US claimed
EP-2225240-A2 DERIVATIVES OF 6-HETEROCYCLIC-IMIDAZOÝL,2-A¨PYRROINE-2-CARBOXAMIDES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF Sanofi-Aventis (FR) 2010-09-08 EP claimed
WO-2009106750-A2 DERIVATIVES OF 6-HETEROCYCLIC-IMIDAZO[L,2-A]PYRROINE-2-CARBOXAMIDES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF SANOFI-AVENTIS (FR) 2009-09-03 WO claimed
US-20070259879-A1 Piperazine and piperidine biaryl derivatives TRIMERIS, INC. 2007-11-08 US claimed
WO-2007103456-A2 PIPERAZINE AND PIPERIDINE BIARYL DERIVATIVES TRIMERIS, INC. (US) 2007-09-13 WO claimed
US-20070155749-A1 DERIVATIVES OF 1,4-DIAZABICYCLO[3.2.1]OCTANECARBOXAMIDE, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS SANOFI-AVENTIS (FR) 2007-07-05 US claimed
CN-1946726-A 1, 4-diazabicyclo [3.2.1] octane carboxamide derivatives, their preparation and use in therapy SANOFI AVENTIS (FR) 2007-04-11 CN claimed
EP-1709052-A1 DERIVATIVES OF 1,4-DIAZABICYCLO 3.2.1OCTANECARBOXAMIDE, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS Sanofi-Aventis (FR) 2006-10-11 EP claimed
WO-2005077955-A1 DERIVATIVES OF 1,4-DIAZABICYCLO[3.2.1]OCTANECARBOXAMIDE, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS SANOFI-AVENTIS (FR) 2005-08-25 WO claimed